268 related articles for article (PubMed ID: 24126219)
21. Predicting Model of Lymph Node Metastasis Using Preoperative Tumor Grade, Transvaginal Ultrasound, and Serum CA-125 Level in Patients With Endometrial Cancer.
Lee J; Kong TW; Paek J; Chang SJ; Ryu HS
Int J Gynecol Cancer; 2016 Nov; 26(9):1630-1635. PubMed ID: 27654258
[TBL] [Abstract][Full Text] [Related]
22. Preoperative and intraoperative assessment of myometrial invasion in patients with FIGO stage I non-endometrioid endometrial carcinoma-a large-scale, multi-center, and retrospective study.
Yang X; Yin J; Fu Y; Shen Y; Zhang C; Yao S; Xu C; Xia M; Lou G; Liu J; Lin B; Wang J; Zhao W; Zhang J; Cheng W; Guo H; Guo R; Xue F; Wang X; Han L; Li X; Zhang P; Zhao J; Li W; Dou Y; Wang Z; Liu J; Li K; Chen G; Sun C; Sun P; Lu W; Yao Q
Diagn Pathol; 2023 Jan; 18(1):8. PubMed ID: 36698195
[TBL] [Abstract][Full Text] [Related]
23. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
24. Preoperative MRI and intraoperative frozen section diagnosis of myometrial invasion in patients with endometrial cancer.
Tanaka T; Terai Y; Ono YJ; Fujiwara S; Tanaka Y; Sasaki H; Tsunetoh S; Kanemura M; Yamamoto K; Yamada T; Ohmichi M
Int J Gynecol Cancer; 2015 Jun; 25(5):879-83. PubMed ID: 25950131
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic parameters in FIGO stage I endometrial carcinoma of endometrioid type].
Stanojević Z; Dordević B
Vojnosanit Pregl; 2006 Dec; 63(12):1006-10. PubMed ID: 17252704
[TBL] [Abstract][Full Text] [Related]
26. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
27. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%.
Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Massuger LF
Gynecol Oncol; 2013 May; 129(2):285-91. PubMed ID: 23422503
[TBL] [Abstract][Full Text] [Related]
28. Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma.
Han G; Lim D; Leitao MM; Abu-Rustum NR; Soslow RA
Histopathology; 2014 Feb; 64(3):389-98. PubMed ID: 24215212
[TBL] [Abstract][Full Text] [Related]
29. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T
Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248
[No Abstract] [Full Text] [Related]
30. A modern assessment of the surgical pathologic spread and nodal dissemination of endometrial cancer.
Praiss AM; Huang Y; St Clair CM; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; Hur C; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2020 May; 157(2):329-334. PubMed ID: 32094021
[TBL] [Abstract][Full Text] [Related]
31. FIGO staging of endometrial cancer: 2023.
Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
J Gynecol Oncol; 2023 Sep; 34(5):e85. PubMed ID: 37593813
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma.
Scholten AN; Smit VT; Beerman H; van Putten WL; Creutzberg CL
Cancer; 2004 Feb; 100(4):764-72. PubMed ID: 14770433
[TBL] [Abstract][Full Text] [Related]
33. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; McKee B; Hoskins WJ; Barakat RR
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):79-85. PubMed ID: 12182977
[TBL] [Abstract][Full Text] [Related]
34. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
[TBL] [Abstract][Full Text] [Related]
35. Endometrioid endometrial carcinomas with microcystic, elongated, and fragmented (MELF) type of myoinvasion: role of immunohistochemistry in the detection of occult lymph node metastases and their clinical significance.
Espinosa I; Serrat N; Zannoni GF; Rovira R; D'Angelo E; Prat J
Hum Pathol; 2017 Dec; 70():6-13. PubMed ID: 28601659
[TBL] [Abstract][Full Text] [Related]
36. The Value of Preoperative CA 125 Levels in Prediction of Myometrial Invasion in Patients with Early-stage Endometrioid- type Endometrial Cancer.
Atguden Z; Yildiz A; Aksut H; Yalcin SE; Yalcin Y; Uysal D; Yetimalar H
Asian Pac J Cancer Prev; 2016; 17(2):497-501. PubMed ID: 26925634
[TBL] [Abstract][Full Text] [Related]
37. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis.
Vargas R; Rauh-Hain JA; Clemmer J; Clark RM; Goodman A; Growdon WB; Schorge JO; Del Carmen MG; Horowitz NS; Boruta DM
Gynecol Oncol; 2014 May; 133(2):216-20. PubMed ID: 24548726
[TBL] [Abstract][Full Text] [Related]
38. The evaluation of reliability and contribution of frozen section pathology to staging endometrioid adenocarcinomas.
Karabagli P; Ugras S; Yilmaz BS; Celik C
Arch Gynecol Obstet; 2015 Aug; 292(2):391-7. PubMed ID: 25608758
[TBL] [Abstract][Full Text] [Related]
39. Lymph node status did not significantly improve the predictability of survival in patients with clinically early-stage endometrial cancer.
Bae HS; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT; Kang S
Int J Gynecol Cancer; 2014 Oct; 24(8):1449-54. PubMed ID: 25180462
[TBL] [Abstract][Full Text] [Related]
40. Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis.
Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Bulten J; Visscher DW; Dowdy SC; Massuger LF
Obstet Gynecol; 2012 Nov; 120(5):1124-31. PubMed ID: 23090531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]